Companies / Dermata Therapeutics, Inc. / Activity
Activity — Dermata Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2025 as of | Elevation Point Wealth Partners, LLC 13F manager | New | Common stock | $8 | +14 | 14 <0.01% of shares | low |
| Q4 2025 as of | Tucker Asset Management LLC 13F manager | New | Common stock | $10 | +35 | 35 <0.01% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | New | Common stock | $349 | +180 | 180 <0.01% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | New | Common Stock | $5.6K | +2K | 2,402 0.06% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common Stock | $24.2K | +19K | 18,747 0.47% of shares | low |
| Q1 2026 as of | Welch & Forbes LLC 13F manager | New | Common Stock | $24.2K | +20K | 20,000 0.50% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | New | Common Stock | $58.5K | +48K | 48,334 1.20% of shares | low |